Pharmacokinetics and Tissue Distribution of Iv Injection of Polyphase Liposome—encapsulated Cisplatin(km—1) in Rats

S Wang,Jb Mi,Yz Li,Wb Chang,Yx Ci,Mz Zhao,Yk Zhao,Ly Zhu,G Xu
2003-01-01
Abstract:AIM The pharmacokinetics and biodistribution of cisplatin encapsulated in polyphase liposome (KM-1) were compared with those of free drug in rats. METHODS The platinum levels in serum and normal organs, after a single dose of iv injection of free or encapsulated cisplatin to rats, were determined by induced coupled plasma atomic emission spectrometry. RESULTS Serum platinum concentration-time curve after a single iv dose of KM-1 4.5 mg/kg in rats was fitted with an open three-compartment model. The pharmacokinetic parameters were as follows: Vc=0.10 L/kg, T1/2pai=0.3 h, T1/2alpha=3.5 h, T1/2beta=2.7 h, AUC=265 mg.h.L(-1), and CL(s) =0.02 g.L.h(-1). KM-1 was cleared from the circulation much more slowly than free cisplatin. Liver and spleen had the highest concentration of platinum after KM-1 treatment. CONCLUSION KM-1 remained in the bloodstream longer than its free drug, and was taken mainly by the reticuloendothelial system.
What problem does this paper attempt to address?